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Summary 
Previously,  hepatic  iron  overload resembling that  in  hereditary  hemachromatosis  (HH)  has 
been found in [32-microglobulin knockout ([32m -/-) mice. We have now characterized iron 
metabolism in [32m -/- mice. The mutant mice fail to limit the transfer of iron from mucosal 
cells into the plasma. Transferrin saturation is abnormally high. Pathologic iron depositions oc- 
cur predominantly in liver parenchymal cells.  Reconstitution with normal hematopoietic cells 
redistributes the iron from parenchymal to Kupffer cells, but does not correct the mucosal de- 
fect. We conclude that (a) iron metabolism is defective in the gut mucosa as well as the liver of 
[32m -/-  mice; and  (b)  a  [32m-dependent gene product is involved in iron homeostasis. Re- 
cently, a novel gene of the major histocompatibility complex class I family, HLA-H, has been 
found to be mutated in a large proportion of HH patients. Our data provide functional support 
for the proposed causative role of HLA-H mutations in HH. 
H 
ereditary hemochromatosis  (HH) 1,  an autosomal re- 
cessive, HLA-linked disease, is one of the most com- 
mon genetic disorders in man. It is characterized by a fail- 
ure in regulation of iron absorption, an increase of transferrin 
saturation,  and progressive iron  deposition predominantly 
in  the  parenchymal  cells  of several  organs  (1).  Increased 
iron absorption in HH homozygotes leads to accumulation 
of iron, with eventual tissue damage and organ dysfunction. 
When the disorder remains untreated, premature mortality 
resulting  from  hepatocellular  carcinoma,  cirrhosis,  cardi- 
omyopathy,  or  diabetes  mellitus  is  common  (2,  3).  Re- 
moval of iron and the prevention of its reaccumulation by 
phlebotomy treatment  dramatically improves life  expect- 
ancy in these patients (4-7). The discovery of a tight linkage 
between HH and the HLA-A locus has led to the clarifica- 
tion of the genetic nature and the autosomal recessive inheri- 
tance of the disease (8, 9). A similar disease is not known in 
animals,  and although  many attempts have been made  to 
develop an appropriate animal model by dietary application 
of different iron compounds, severe organ damage as seen 
in HH could not be reproduced in these models (10). 
1Abbreviations used in this paper. [32m, [32-rmcroglobuhn; [32m /% 132m 
knockout (mice); Hb, hemoglobin; HCT,  hematocnt; HH, hereditary 
hemachromatosls; IR, iron retention; MCV, mean corpuscular volume; 
MT, mucosal transfer fraction of iron; MU, mucosal uptake of iron; RE, 
reticuloendothehal; TIBC, total iron-binding capacity;  TS, transfernn sat- 
uration. 
In a  previous study,  we  have revealed the  existence  of 
hepatic iron overload in [32-microglobulin ([32m)-deficient 
mice similar to that found in HH (11,  12).  This was based 
on a histological and quantitative study of the steady-state 
iron  distribution  and  content  in  tissues  of [32m -/-  mice. 
These results were confirmed more recently by others (13). 
In  addition,  the  latter  study  demonstrated  that  increased 
levels of dietary iron led to accelerated iron accumulation, 
and reported an increased incidence ofhepatocellular carci- 
noma  in  132m knockout  mice.  Such  carcinomas  are  fre- 
quently seen in HH patients. 
In this report, we characterize the nature of the iron me- 
tabolism defect found in [32m -/- mice. [32m is required for 
the  normal surface  expression of classical  and nonclassical 
MHC  class  I  molecules  (14,  15).  Thus,  mice  lacking  a 
functional [32m gene fail to express MHC class I products 
(16,  17).  Such mice lack CD8 + lymphocytes. To analyze a 
possible involvement of CD8 + cells, we also analyzed iron 
metabofism in CD8 -/- mice. Mice that are mutant in the 
TAP-1  peptide  transporter do  not  express classical  class I 
molecules on the surface of their cells (18).  Some nonclassi- 
cal MHC-I molecules can be  expressed independently  of 
TAP function, however (19, 20). Therefore, to extend our 
analysis  of the nature of the [32m-dependent molecules in- 
volved in iron metabolism, we included the TAP1-/- mice 
in our study.  [32m -/- mice failed to reduce intestinal iron 
absorption in the face of iron overload and had abnormally 
high  (>80%)  values  of transferrin  saturation.  This  defect 
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TAP1 -/-  mice and CD8 -/-  mice was  comparable to  that 
of controls.  Additional  results  are  presented  that  suggest 
that the iron metabolism in 132m  -/-  mice is affected at the 
level of the gut mucosa, as well as at the level of iron stor- 
age in Kupffer cells. 
The results presented here reveal a  remarkable similarity 
between iron metabolism in ~32m -/-  mice and in HH  pa- 
tients,  and support  the  unexpected involvement of MHC 
class I-like molecule(s) in the regulation of iron homeostasis. 
Materials and Methods 
Mice.  C57BL/6  (B6)  female  mice  aged  6-8  wk  were  pur- 
chased  from  IFFA Credo  (Brussels,  Belgium), and used as con- 
trols. The f32-rmcroglobulin "knockout" (132m  -/-) mice (16) were 
purchased  from  Jackson  ImmunoResearch  Laboratories  (West 
Grove, PA) and further bred in our animal facility; CD8  /- lmce 
(21)  were  obtained from  Dr.  T.  Mak  (University of Toronto, 
Toronto, Canada), and further bred in our animal facility. Both 
mutant mice  had  been back-crossed  onto  the  C57BL/6  back- 
ground.  Liver  samples  from  TAP-/-mice  (18)  were  obtained 
from Dr.  S.  Tonegawa  (Massachusetts  Institute of Technology, 
Cambridge). All animals were given a commercial diet (RMH-B®; 
Hope Farms, Woerden, The Netherlands) or, when indicated, an 
iron-enriched diet containing 2.5% (wt/wt) carbonyl iron (Sigma 
Immunochermcals, St. Louis, MO) for 14 d. 
For all animal experiments, wntten consent was obtained from 
the local Animal Experiments Committee of Utrecht University 
(Utrecht, The Netherlands). 
Transferrin Saturation and Hematological Measurements.  Heparinized 
blood was obtained by orbital puncture under diethylether anes- 
thesia. Hemoglobin (Hb), hematocrit (HCT), and mean corpus- 
cular volume (MCV) were determined using a Coulter-S counter 
(Coulter Electronics, Hialeah,  FL).  Plasma iron and total  iron- 
binding  capacity  (TIBC)  were  determined  by  the  Ferrozine 
method (Iron FZ Test; Roche, Basel, Switzerland) with the CO- 
BAS-BIO autoanalyzer (Hoffman-La Roche BV, Mijdrecht, The 
Netherlands). Transferrin saturation (TS) was calculated from the 
TIBC and plasma iron values. 
Histology.  Samples  of liver, spleen,  kidney,  heart,  and pan- 
creas were fixed in 4% buffered formaldehyde. After routine his- 
tology processing, the paraffin sections were stained by hematox- 
yhn  and  eosm.  For  the  detection  of  ferric  iron  (Fe3+),  the 
Prussian blue stain was used (22). 
Measurement of Liver Iron  Concentration.  Liver  samples  were 
weighed wet, then dried overnight at 106°C and weighed again. 
The dned samples were ashed in an oven at 500°C for 17 h, then 
fully solubihzed in 6 M  HC1, and the final solution was adjusted 
with demineralized water to a final HC1 concentration of 1.2 M. 
Iron  concentration  of  the  samples  was  determined  by  flame 
atomic  absorption  spectrometry  (Varian  SpectrAA  250  Plus; 
Varian, Mulgrave, Victoria, Austraha). 
Electron Microscopy.  Small pieces of liver were fixed in a mod- 
ified Karnovsky fixative consisting of 2.5% glutaraldehyde and 2% 
paraformaldehyde in 0.1  M  Na-cacodylate buffer, supplemented 
with 2 mM CaCI  2, for at least 24 h at 4°C. The tissue was washed 
twice with the same buffer, postfixed in 1% OsO4, and embedded 
in Epon 812.  1-mm semithin sections were stained with methyl- 
ene blue and pararosanilin (23).  Ultrathin sections (60 nm) were 
cut and contrasted with 3% uranyl magnesium acetate for 45 rain 
at 63°C followed by Reynolds' lead citrate for  10 min. Stained 
and unstained sections were  viewed in an electron microscope 
(201c; Philips Technologies, Chesire, CT). 
Gastrointestinal  Iron Absorption.  For iron absorption tests,  the 
mice were fasted for 6  h  and housed for 3  d  in cages  equipped 
with grates to minimize coprophagy. 
All test doses were  freshly prepared  and were  administered 
in aqueous solution using demineralized water.  SgFe(III)  citrate 
was added to Fe(II) as ferrous sulfate and a 20X  molar excess  of 
1-ascorbic acid solution to reduce the Fe(III). SlCrC13 was added 
as a nonabsorbable indicator. The total amount of Fe(II) per test 
dose was 5 ~g per mouse and had a final volume of 0.3 ml. Each 
mouse received °°50 kBq of SgFe and 200 kBq of SlCr. 
The test dose was orally applied with the use of an olive-tipped 
oroesophageal  needle.  Total  body  radioactivity  was  measured 
with a whole-body gamma counter (Automatic Scanner DS4/4S; 
Tracelab Ltd.,  Weybridge, Surrey, UK) with separate  detection 
windows tbr 5VFe and SlCr peaks. The values were corrected for 
radioisotope  decay  and  day-to-day  fluctuations  of the  scanner 
with the use of a radium source. The SlCr peaks were corrected 
for the Compton effect of SgFe. 
Mucosal uptake of iron (MU) was calculated from the activity 
of 59Fe and SlCr administrated (measured immediately after test 
dose administration and considered as 100%),  as well as from the 
activity of 59Fe (F1)  and SlCr (C1)  found within the body 22 h 
later, using the formula MU =  100 X  (F1  -  C1)/(100  -  C1)%. 
F1  and C1  were  expressed  as the percentage of the  amount of 
SgFe andSlCr administered. 59Fe retention (IR) was determined by 
whole-body counting 7  d  after administration of the  test  dose. 
The mucosal transfer fraction of iron (MT) was determined as the 
ratio IR/MU. 
When the animals were tested twice for iron absorption, the sec- 
ond test dose was administered 16 d after the first dose. Background 
values of the first test dose were corrected for radioisotope decay. 
Fetal Liver Cell Transfer.  Recipient animals were lethaly irra- 
diated (9.5  Gy) and reconstituted with 5-10  X  106 day 13 fetal 
liver cells by intravenous injection. Chimeras were kdled at 4, 8, 
and 12 wk after reconstitutlon, and chimerism was monitored by 
FACS  ® (Becton  Dickinson, Mountain View,  CA)  using CD4, 
CD8  (PharMingen, San Diego,  CA),  and H141.31.10  (anti-K  b) 
antibodies. 
Statistical Analysis.  Results are presented as the mean +  SD. 
Student's t test was used for comparison between the control and 
knockout  mouse  groups.  For  individual comparisons between 
two measurements, the paired t test was used. The level of sigmf- 
lcance was preset at P <0.05. 
Results 
Increased Plasma Iron and TS in ~2rn  /- Mice.  Under  nor- 
real  circumstances,  the  vast  majority  of  plasma  iron  is 
bound to transferfin. Transferrin-bound iron is transported 
to various sites of utilization, where  it is delivered to  cells 
via transferrin receptors (24). In HH  homozygotes, the ear- 
liest laboratory abnormalities are elevated plasma iron con- 
centrations and increased TS  (25,  26).  Therefore, we mea- 
sured  plasma  iron  and  TIBC,  and  calculated  transferrin 
saturation  from  that  in  2-  and  12-too-old  mice.  At both 
ages,  f32m  -/-  mice  had  persistently  higher  plasma  iron 
concentrations (Fig.  1 A) and TS  (Fig.  1 B)  than either B6 
or CD8 -/-  control mice. 
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Figure  1.  Increased iron levels 
m [32m  -/- rmce. (A) Plasma ~ron 
and  (/3) TS  in  B6  (control), 
[32m-/-, and CD8 -/- mice aged 
2  and  12  too.  Plasma  iron  and 
TIBC  were  determined  by  the 
Ferrozine method. TS was calcu- 
lated  from  the  ratio  of plasma 
iron and TIBC. Values represent 
mean  +  SD.  Mean values  from 
132m  -t-  mice  were stgmficantly 
&fferent  from  that  for  B6  or 
CD8 -/-  mace (Student's  t test): 
P  <0.001.  (C)  Iron  concentra- 
tion m hvers. Lwer samples from 
B6,  [32m  -/-  CD8 -/-,  and 
TAP1 -/-  mice  aged  2  and  12 
mo  were  analyzed  by  flame 
atomic  absorption  spectrometry 
for  quantitative  determinauon 
of  iron.  Individual  values  are 
represented.  Mean  values  from 
~32m  -I-  mice  were  stgmficantly 
&fferent  from  those  of  B6  or 
CD8 -/-  mice  (Student's  t test): 
P <0.0001. 
Increased iron Concentrations  in  Livers from  fl2m -/-  Mice. 
Diagnosis  of iron storage disease  normally requires a  biopsy 
of the  liver,  the  major  organ  for  excess  iron  storage  (1). 
Further quantitative determination of the hepatic  iron con- 
centration, histochemical visualization of the cellular distri- 
bution  of iron,  and pathological examination  of the  extent 
of injury  provide  essential  information  about  the  type  and 
degree of iron loading. 
Confirming  the  finding reported  earlier  (11,  13),  8-wk- 
old  [32m -/-  mice  had  hepatic  iron  concentrations  that 
were  more  than  twice  as  high  as  in  B6  control  mice.  In 
contrast,  iron  concentration  in  the  livers  of CD8 -/-  mice 
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Figure 2.  Storage  of excess iron In hepatic cells ofrmce fed with different diets (Prussian blue staining). (A and B) Light micrograph ofa hver secnon 
from B6 (indicated as ~32m  +/+, A) and [32m  -/- (B) mouse aged 2 mo and fed with a standard diet. In the hver of the [32m  -/- mouse, liver parenchymal 
cells with an increased iron content are visible around portal spaces. (C and D) Light micrograph ofa hver section from B6 (indicated as [32m  +/+, C) and 
[32m  -/- (D) mouse aged 2 mo at the start of the experiment and fed with an Iron-enriched diet (2.5% wt/wt carbonyl iron) for 2 wk. Beside  parenchymal 
cells, heavily  iron-loaded Kupffer  cells  are visible m the [32m  +/+ hver. Kupffer cells are indicated with arrows. Original magmficatmn ×300. 
and  TAP1  /-  mice  were  comparable to  B6  control mice 
(Fig. 1 C). Similar observations were made at 12 mo of age, 
when  [32m -/-  mice  had  accumulated  about  three  times 
more iron in their livers than age-matched B6, CD8 -/-, or 
TAP1 -/-  mice (Fig. 1 C). 
Celhdar Distribution of Storage Iron in Livers.  One  of the 
distinguishing features of the pathology in HH in humans is 
that  the  initial deposition of iron is predominantly in the 
parenchymal cells of affected tissues, with insignificant early 
involvement of macrophages of the reticuloendothelial sys- 
tem  (27).  No detectable iron was seen histologically in B6 
(Fig. 2 A), CD8  /  , and TAP1-/-  mice (not shown) of var- 
ious ages that were fed with a  standard diet. Prussian blue 
staining of hver sections from >50  [32m -/-  rmce revealed 
a predominant presence of iron in parenchymal cells (Fig. 2 
B),  confirming  the  finding  reported  earlier  (11,  13).  At 
early stages, the iron-loaded hepatocytes were concentrated 
in periportal areas, but later they were  distributed equally 
throughout  all areas  of the liver lobule.  In  older animals, 
iron depositions were also present in the pancreas, kidneys, 
and heart (not shown). Two  out of seven 1-yr-old [32m -/- 
mice had  a  sevenfold increase in liver iron concentrations 
(Fig. 1  C) and had developed hepatic fibrosis (not shown), 
which was never seen in control mice of the same age. 
Examination  of livers  from  [32m -/  mice  by  electron 
microscopy revealed electron-dense lysosomal structures in 
hepatic parenchymal cells located in periportal areas. These 
lysosomes had a granular substructure (Fig. 3 A) and, in un- 
stained  sections,  they  were  composed  of  more  or  less 
densely packed ferritin granules. Significant amounts offer- 
ritln granules were also present in the cytoplasm of hepatic 
parenchymal cells (Fig. 3 B). Of interest, lysosomal deposits 
of ferritin  and  hemosiderin are prominent  in  the  hepato- 
cytes of patients with HH. 
To study the effects of iron overloading on the iron stor- 
age in the liver, animals were fed a diet supplemented with 
2.5% (wt/wt) ofcarbonyl-iron for 14 d. In B6 and CD8 -/- 
mice, iron deposition was present in hepatocytes, but was 
particularly prominent in Kupffer cells (Fig. 2  C).  In con- 
trast, in dietary iron-loaded [32m  -/- mice, the iron continued 
to be found predominantly in parenchymal cells (Fig. 2 D). 
Erythroid Parameters.  Excess storage iron can occur in a 
large  group  of hematological diseases,  collectively termed 
iron-loading anaemias,  in which  ineffective erythropoiesis 
or  abnormalities  of hemoglobin  synthesis  are  prominent 
(1). They are characterized by anemia and a subsequent in- 
crease in iron absorption. Ultimately, the inefficient use of 
the iron leads to iron overload. To rule out the possibility 
that  anemia  could  account  for  the  abnormal  iron  storage 
defect demonstrated in [32m -/-  mice, we determined sev- 
eral  erythroid  parameters.  The  results  demonstrated  that 
P,  BC  counts,  Hb,  HCT,  and  MCV  values  were  even 
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higher in the [32m -/-  mice than in the other animal groups 
(Table  1).  Thus,  the excess storage iron found in ~2m -/- 
mice could not be related to defective erythropoiesis or Hb 
synthesis. 
Failure  to  Regulate  Iron  Absorption  in  ~2m -/-  Mice. 
One  of the  hallmarks  of iron  homeostasis  is  its  exclusive 
regulation at the sites of absorption (28,  29).  The  capacity 
to reduce or increase absorption of iron in response to in- 
creased or reduced iron stores is well documented. In HH, 
patients fail to decrease their iron absorption despite the ac- 
cumulation of iron in the body (30-32). 
Iron  retention,  here  defined  as  the  percentage  of 59Fe 
found in the body 7 d after the administration of an oral ra- 
dioactive test dose, was plotted against iron concentration 
1979  Santos et al. 
Figure  3.  Intracellular  distri- 
bution of excess iron in [32m  / 
hepanc  parenchymal  cells  (A) 
Electron macrograph of a hepatic 
parenchymal cell from a  12-mo- 
old  J32m  /-  mouse  fed  with  a 
standard  diet.  Numerous  iron 
contalmng lysosomes are present 
m  the  Golgi  area  (arrowheads). 
Bar, 0.5 ram.  (B)  Unstained sec- 
tion  showing  in  detail  lysomal 
structures  (arrowheads)  contain- 
mg densely packed ferritm pal-ti- 
des  Ferritin  particles  are  also 
present  in  the  cytoplasm,  scat- 
tered (arrows) or in small clusters 
(double arrow). Bar, 0.1 ram. 
in livers (Fig. 4 A). Despite the fact that J32m -/-  mice have 
increased  amounts  of iron  m  livers when  fed  a  standard 
diet, they did not  downregulate  their IR  as  compared to 
control B6 mice that were fed the same standard diet. Im- 
portantly,  B6  rmce  that  were  fed  an  iron-enriched  diet 
promptly downregulated  IR  as  a  response  to  the  modest 
increase of iron in their livers. 
To  test whether  [32m -/-  mice  can  downregulate  iron 
absorption as a  response  to  a  similar overload induced by 
diet, iron retention was measured before and after feeding 
the animals with an iron-enriched diet for 14 d. Again, the 
downregulation of IR in response to moderately increased 
iron stores could readily be demonstrated in B6 and CD8 -/- 
mice.  In marked  contrast to  the  results observed in  these Table  1.  Erythroid  Parameters 
Mice  Age  n  RBC  Hb  HCT  MCV 
mo  1012~liter  mmol/liter  %  fl 
B6  2  19  9.4 +  0.3  8.9  +  0.3  45  +  1  48 +  1 
B6  12  6  8.7  +  0.5  7.9 +  0.5  40 +  2  45  +  1 
[32m -/-  2  11  10.0  +  0.4  10.2  +  0.5  53  +  2  53 +  1 
~2rn -/-  12  6  10.4  +  0.3  10.2  +  0.3  51  +  1  49 +  2 
CD8 -/-  2  13  9.0 +  0.3  8.6 +  0.3  44 +  1  49 +  2 
CD8 -/  12  6  8.7  +  0.7  8.0 +  0.5  40 +  1  46 +  1 
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mice,  ]32m -/-  mice,  even  when  challenged  with  high 
dietary  iron,  were  unable  to  reduce  their  iron  retention 
(Fig. 4/3). 
A  more  specific  indicator  of the  regulation  of iron  ab- 
sorption  is  the  so-called MT,  here  defined  as  the  ratio  of 
the iron ultimately retained in the body vs. the iron initially 
taken up by the gut mucosa.  This is believed to be the crit- 
ical step  that  is  defective in  HH  patients  (33).  We  used  a 
double-isotope  technique  (32;  Santos,  M.,  K.J.H.  Wienk, 
M.W.  Schillaam, H.  Clevers,  M.  DeSousa,  and J.J.M.  Marx, 
manuscript  in  preparation)  to  discriminate  between  initial 
MU  and subsequent iron retention, and hence calculate MT 
of iron. The MT  in [32m -/-  mice that were maintained on 
a  standard  diet was  consistently higher than MT  in normal 
or CD8 -/-  mice  (Table  2).  After experimental iron over- 
load,  MT  in  B6  and  CD8 -/-  mice  was  strongly  reduced, 
whereas  MT  in  [32m -/-  mice  was  only  mildly  decreased 
(Fig. 4  C). 
Taken together, the capacity of [32m -/-  mice to regulate 
iron  absorption  in  response  to  changes  in  iron  stores  was 
strikingly affected at the level of the MT  of iron to the plasma. 
Fetal Liver Cell Transfer.  As  an  alternative  site  for  the 
primary  iron  handling  defect  in  HH  patients,  the  reticu- 
loendothelial  (RE)  system has  been proposed.  Specifically, 
it has been shown that the RE  cells in HH  patients are im- 
paired  in  their  capacity  to  store  iron  (34-36).  A  possible 
implication  of these  studies  is  that  an  abnormality  in  RE 
iron metabolism might affect the control of iron absorption 
by the intestinal mucosa (37).  We attempted  to address this 
issue  by  reconstituting  lethally  irradiated  [32m -/-  mice 
with  hematopoietic  cells  from  normal  mice.  It  was  ex- 
pected that if RE  cells play a role in regulating iron absorp- 
tion,  [32m-/--reconstituted  mice should be able to  correct 
their  abnormalities  in  iron  homeostasis.  All  [32m -/-  mice 
reconstituted  with [32m  /  -derived cells had stainable  iron 
in parenchymal  cells, and they were indistinguishable  from 
untreated  [32m -/-  mice  (Figs.  2  B  and  5,  A  and  C).  No 
stainable  iron  was  detected  in  B6-reconstituted  B6  mice 
(not  shown).  All  attempts  to  reconstitute  B6  mice  with 
[32m -/-  fetal liver cells failed, most likely because of rejec- 
tion  of the  transplanted  hematopoietic  cells  by  host  NK 
cells (38).  A  striking change in hepatocelhilar iron distribu- 
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groups were maintained  on a standard diet. Each group  of mace (n =  8) 
was given a radioacuve test dose soluuon.  IR was deterrmned  at day 7 m 
a whole-body counter  Liver samples were analyzed by flame atomac ab- 
sorpuon  spectrometry  for quantitative  determinauon  of iron  Individual 
values for each mouse are shown.  (B) Ilk and (C) MT in the same mace 
before (O) and after iron loading (Q) with carbonyl iron (2.5% wt/wt) for 
14 d (six mace per group).  Control B6 mace were maintained  on a stan- 
dard diet  IR was measured  at day 7 after the admamstration of the test 
dose. Mucosal transfer of iron was calculated from the ratio IR/MU. In- 
dividual values for each mouse are shown. 
1980  Iron Metabolism in [~2m  -/- Mice Table 2.  Increased  Intestinal MT in ~82m-/- Mice 
B6  CD8 -/-  [32m -/.  P 
Age  n  MT  n  MT  n  MT  vs. B6  vs. CD8 -/- 
mo 
2  12  0.74  +  0.06  6  0.72  ±  0.06  6  0.89  +  0.04  <0.0001  <0.0005 
4  8  0.74  -+ 0.04  5  0.64  ±  0.04  7  0.86  -4- 0.05  <0.0001  <0.0001 
6  7  0.70  ±  0.04  6  0.72  ±  0.05  6  0.82  -4- 0.05  <0.001  <0.005 
12  6  0.64  -+ 0.05  6  0.65  --_ 0.05  6  0.86  -+ 0.06  <0.0001  <0.0001 
MT was deterrmned as the ratio of IR/MU. Each mouse recmved orally a double ~sotope test dose containing SgFe and SlCr. MU was calculated  1 d 
later. 59Fe retention was determined by whole-body counnng 7 d after adn'nnistration  of the test dose. Data are presented as mean -+ SD. n =  num- 
ber ofammals; P =  Student's t test for comparison ofl32m  -/  mice with B6 control and CD8 -/  mace. 
tion was observed in [32m  -/-  mice at 1 (Fig. 5  B) and 2 mo 
(not  shown)  after  reconstitution  with  B6  hematopoietic 
cells:  the site of storage of excess iron shifted from paren- 
chymal to Kupffer cells. Total liver iron concentrations, as 
measured by  flame  atomic  absorption spectrometry,  only 
showed a  slight decrease (not shown). 3  mo after reconsti- 
tution, no stainable iron was observed in five out of seven 
treated mice (Fig. 5  D). Despite the decrease in iron depo- 
sition in  the livers of B6-reconstituted 132m  -/-  mice, he- 
matological parameters and TS  were still increased during 
the  experimental period.  This  probably reflected a  failure 
to  correct  the  increased iron  absorption by  the  intestinal 
mucosal cells.  Indeed, mucosal transfer in  [32m  /  mice 
3  mo  after reconstitution with  either [32m  -/-  cells or B6 
3 months 
132m-/-  =  132m-/-  ..,  B6  132m-/-  , 
1 month 
•  ,~  ......  :~  "  ~'~  , 
...it,  ... 
Figure 5.  Liver iron m radxation chxmeras (Prussxan blue staining). All animals were 6 wk old at the start of the experiment.  (A and C') Liver sections 
from [32m  /  mace 1 mo (.,'t) and 3 mo (C) after reconstitution  with fetal hver cells from [32m  -/- donor mace. (B and D) Liver sections from [32m  -/- 
mace 1 mo (B) and 3 mo (D) after reconstltuUon with fetal liver cells from B6 donor mice  Heavily Iron-loaded Kupffer cells (arrows)  are vxsxble 1 mo after 
reconstltUtlOn. After 3 mo, no iron deposmons are present. Original magnification X300. 
1981  Santos et al. hematopoietic cells was higher (MT  =  0.86  -+ 0.04; n =  5 
and MT  =  0.84  +  0.05;  n  =  5,  respectively)  than in B6 
mice  reconstituted  with  B6  hematopoietic  cells  (MT  = 
0.67  +  0.05; n =  5).  These results suggest that hematopoi- 
etic cells  have no influence on iron absorption at the level 
of the gut mucosa. They indicate,  however, that such cells 
affect the pattern of cellular iron storage an the liver. 
Discussion 
Previously,  we  have  reported  the  existence  of hepatic 
iron overload in [32m  -/- mice similar to that found in HH 
(11). This was based on a histological and quantitative stud- 
ies of the  steady-state  iron distribution  and  content in tis- 
sues of [B2m  -/-  mice.  These results were confirmed more 
recently by others (13). 
Now we  report  a  detailed  analysis  of the  nature  of the 
iron metabolism defect of 132m  -/- mice. These mice reca- 
pitulate all central features of HH; i.e., increased TS, visible 
iron  depositions,  specifically  in  parenchymal  ceils  of the 
liver, and a dysregulanon of intestinal iron absorption.  The 
defect  appears  to  be  caused  by the  lack  of a  class  I-like, 
132m-dependent molecule, and not by the lack ofCD8 + T 
cells  or TAP-dependent  MHC  molecules.  Moreover,  al- 
though  the  storage  abnormalities  in  the  liver  of [32m  -/- 
mice can be compensated by cell transfer,  the increased in- 
testinal iron absorption is not reduced by substitution of the 
hematopoietic compartment. 
Intestinal Iron Absorption.  The capacity of [32m  /- mice 
to  regulate  intestinal  iron  absorption  in  the  face  of in- 
creased iron stores seems to be manifestly impaired.  Simi- 
larly, in HH, patients fail  to decrease  their iron absorption 
despite the accumulation of iron in the body (30-32). 
Iron retention is only the ultimate  result of the iron ab- 
sorption process, which can be divided into two steps: MU 
from  the  intestinal  lumen  and  the  subsequent  transfer  of 
iron through mucosal  cells  into  the  blood.  Under normal 
conditions,  not all  the  iron is  transferred  into  the  circula- 
tion, but remains inside the mucosal cell and is rapidly lost 
after desquamation of the epithelial cells.  MU is influenced 
by many intraluminal  factors:  the  state  of the  iron  in  the 
test dose (ferric or ferrous, heme or nonheme), the amount 
of iron, the composition of the test dose, gastric and intesti- 
nal secretions, and the state of the brush border of the mu- 
cosal cells.  The  next step,  MT,  is less  dependent  on these 
intraluminal factors and will better reflect the iron status of 
the body.  In [32m  -/  mice, MT of iron into the plasma is 
invariably increased, even under normal dietary conditions. 
Importantly, MT  is believed  to be  the  critical  step  that  is 
defective in HH patients  (33).  Under increased iron load- 
ing, the differences between normal and [32m  -/- mice be- 
come accentuated,  as the  [32m  -/-  mice fail  to downregu- 
late MT and iron retention. 
Cellular Iron Storage.  The  parenchymal  iron  accumula- 
tion in the livers of[32m  /  mice resembles that of HH pa- 
tients  and  contrasts  with  the  histopathological  findings  in 
other  iron  storage  disorders  in  man.  The  amount  of de- 
monstrable iron in macrophages in HH is minimal until the 
late stages of the disease  (27,  39-42).  By contrast, iron ac- 
cumulation in the overload diseases Bantu siderosis (in Af- 
rica)  and Kaschin-Beck (in Asia) is prominent both in mono- 
nuclear phagocyte system cells and in hepatic parenchymal 
cells  (43-45).  The  organ  damage  that  occurs  in  HH  pa- 
tients  subsequent  to  the  iron  accumulation  (e.g.,  liver  fi- 
brosis,  cirrhosis,  hepatocellular  carcinomas,  and  diabetic 
hyperglycemia caused by pancreatic  islet  destruction)  also 
occurs in old [32m  -/- mice (13, 46). 
The relevance of the observed iron storage abnormalities 
in  [32m  -/-  mice  emerges  from  numerous  studies  per- 
formed in animals in an attempt to mimic HH  (47-51).  In 
these studies, excess dietary iron alone failed to produce the 
typical  parenchymal  iron  accumulation  and  the  resulting 
organ damage,  even when iron concentrations in the liver 
were three to four times higher than the critical iron level 
associated  with  fibrosis  in  HH  (52).  In  accordance  with 
these  findings,  we  observed  heavily  iron-loaded  macro- 
phages in livers from control B6 mice after dietary manipu- 
lation. Apparently, surplus iron is redistributed from paren- 
chymal cells  to the mononuclear phagocyte system in liver 
of dietary iron-loaded animals  (53).  This notion is consis- 
tent with previous studies that show a decreased iron stor- 
age capacity of macrophages in HH (35, 36, 54).  Similarly, 
it would appear that the Kupffer cells of 132m  /- mice fall 
to store excess iron, even when surrounded by iron-loaded 
parenchymal  cells.  The  apparent  redistribution  of stored 
iron from parenchymal to KuptTer cells upon transfer ofhe- 
matopoletlc ceils  might suggest that  [32m  -/-  Kupffer cells, 
like HH macrophages, carry an Intrinsic defect in iron storage. 
Molecular Nature of the Defect.  [32m  is  required  for  the 
normal surface  expression  of classical and nonclassical MHC 
class  I molecules  (14,  15).  Thus,  mice lacking a functional 
[32m gene  fail  to  express  MHC  class  I  products  (16,  17), 
and consequently they lack CD8+  lymphocytes. 
The TAP-1  and TAP-2 proteins  are required for trans- 
port ofcytosolic peptides into the endoplasmatic reticulum for 
association with classical  class  I molecules  (55-57).  TAP-1 
mutant mice are deficient in peptide  transport,  and conse- 
quently do not express classical  class I molecules on the sur- 
face of their  cells  (18).  Recently,  it was shown  that some 
nonclassical MHC  I molecules may be expressed indepen- 
dently  of TAP  function  (19,  20).  Livers  from  TAP1 -/ 
mice had normal iron concentration values,  implying that 
classical  MHC  class I molecules are not responsible for the 
observed iron storage phenotype in [32m  /- mice. Rather, 
it would appear that a "nonclassical,"  [32m-associated mol- 
ecule performs a function in iron metabolism.  Such a mol- 
ecule would be dependent on the presence of [32m, but in- 
dependent of TAP function. 
The  gene  responsible  for HH  has  been  located  on  the 
short  arm  of chromosome  6,  in  linkage  desequilibrium 
with  the  HLA-A locus  (8,  58),  where  several  nonclassical 
MHC-I genes have been identified (59-61). While this pa- 
per was under submission,  a novel MHC  class I-like gene, 
termed HLA-H, was reported to be mutated in a large ma- 
jority  of HH  patients  (62).  Two  missense  variants  were 
found in 87% of HH patients.  Importantly, the most preva- 
1982  Iron Metabohsm in [32m  -/- Mice lent  mutation  was  inferred  to  disrupt  the  putative  [32m- 
binding  site  on  the  HLA-H  molecule.  The  current  data 
lend independent, functional support for a causative role of 
HLA-H mutations in HH. 
Iron Homeostasis.  One of the hallmarks of iron homeo- 
stasis is  its exclusive regulation  at the  sites of absorption 
(28,  29).  It is not clear yet what mechanism regulates iron 
absorption  from  the  gut,  but  two  main  hypotheses  have 
been  suggested  from  observations  made  in  HH  patients. 
One assumes a generalized defect in iron storage in the RE 
system  and  in  the  feedback regulation  of iron  absorption 
(37).  The other hypothesis assumes a direct role of the in- 
testinal mucosal cells in regulating iron absorption (63-68). 
Our  results in the  reconstituted  [32m -/-  mice  supports 
the  view  that  the  primary  iron  metabolism  defect  is  ex- 
pressed  both  at  the  level  of the  gut  epithelium  and  of 
Kupffer cells in the liver. The histopathological analysis in- 
dicated that the liver iron storage pattern was normahzed, 
indicating the involvement of hematopoietic-derived cells, 
Kupffer  cells  or  others,  in  the  regulation  of cellular iron 
storage in the liver. However, the iron absorption defect of 
the mucosal intestinal cells could not be  corrected by the 
transferred  cells.  The  defect  appears  not  to  reside  in  the 
liver parenchyma. Consistent with this view is the observa- 
tion that inadvertently transplanted livers from HH patients 
into recipients with otherwise normal iron metabolism re- 
turned  to  normal  iron  concentrations  (69-71).  In  these 
documented cases, a diseased liver was transplanted into re- 
cipients with  normal hematopoietic compartment and gut 
mucosa.  We  propose that  HLA-H  is responsible for both 
primary  metabolic  defects  in  HH,  namely  the  pattern  of 
iron accumulation  in  the  liver and  the  failure to  regulate 
iron absorption. 
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